Pulse Biosciences (Nasdaq: PLSE): Join the Future of Bioelectric Medicine

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ (nanosecond Pulsed Field Ablation) technology delivers nanosecond pulses of electrical energy to non-thermally ablate cells while sparing adjacent noncellular tissue.

The Company is actively pursuing the development of its CellFX nsPFA technology for use in the surgical treatment of atrial fibrillation and percutaneously in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Visit pulsebiosciences.com to learn more.

Why Join Us?

At Pulse Biosciences, we are driven by purpose and innovation.

Our Mission: To build a viable Company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients. To solve the needs of patients, physicians, and healthcare providers with high quality and high reliability products and services, developed in accordance with rigorous scientific, engineering, and clinical standards. We exist to make a positive difference in the lives of patients, physicians, healthcare providers, shareholders and our Pulse Biosciences team members.
Our Culture: A community of creative, forward-thinking individuals tackling challenges with ingenuity and collaboration.
Our Commitment: Hiring the best and brightest minds to advance our world-class organization.

What You Will Experience

Culture and Purpose - Purposeful and rewarding work collaborating with bright and curious minds brings us together!
Innovative Environment - An environment that fosters innovation to take products from concept to human use quickly!
Growth Opportunities - Learning culture focusing on professional and personal growth and development that you can only get in a startup-like environment!
Comprehensive Benefits - A variety of health insurance plans and supplemental insurance options, and 401k retirement savings plan.
Ownership and Rewards - Stock options awards and Employee Stock Purchase Plan (ESPP) to share in our success.
Work-Life Balance - Enjoy paid time off, paid holidays, flexible work schedule and wellness program, including onsite gym and mindfulness classes.
Diversity & Inclusion - A commitment to providing a respectful work environment to our diverse workforce.

About the Role

The Director of Clinical Affairs - Minimally Invasive Surgery Market (e.g., Thyroid) is responsible for the successful planning, directing and execution of the minimally invasive surgery market portfolio. The position requires maintenance of up-to-date knowledge of all applicable US, international regulation and regulatory guidance for the conduct of clinical trials in compliance with all sponsored protocols, Good Clinical Practices (GCPs), Standard Operating Procedures (SOPs), as well as in-depth product and clinical knowledge of indications. She/he brings strong leadership, problem-solving, and decision-making abilities.

To Make an Impact, You Will

Provide operational expertise into the planning, implementation, and execution of clinical trials to obtain new or specific indication associated with the CellFX nsPFA percutaneous electrode system in accordance with project timelines, budget, and quality standards.
Participate in discussions with cross functional product development teams on a regular basis and create documents required for clinical readiness.
Contribute to the design of clinical trials including protocol development, informed consent form, case report forms/procedural worksheets, questionnaires, management of trial master files, and development of timelines, milestones, project plans/deliverables in conjunction with the research team.
Conduct literature review for clinical documents (e.g., Report of Priors Investigation (ROPI) and Investigator Brochure (IB).
Support training of internal staff, study investigators and other site personnel on the proper conduct of the trial and the review of specific product performance specifications.